Search Results - Knott, Adam

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Event-free survival in patients with early HER2-positive breast cancer with a pathological complete response after HER2-targeted therapy: a pooled analysis by Swain, Sandra M. (Author) , Macharia, Harrison (Author) , Cortes, Javier (Author) , Dang, Chau (Author) , Gianni, Luca (Author) , Hurvitz, Sara A. (Author) , Jackisch, Christian (Author) , Schneeweiss, Andreas (Author) , Slamon, Dennis (Author) , Valagussa, Pinuccia (Author) , Du Toit, Yolande (Author) , Heinzmann, Dominik (Author) , Knott, Adam (Author) , Song, Chunyan (Author) , Cortazar, Patricia (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 stu... by Swain, Sandra M. (Author) , Miles, David (Author) , Kim, Sung-Bae (Author) , Im, Young-Hyuck (Author) , Im, Seock-Ah (Author) , Semiglazov, Vladimir (Author) , Ciruelos, Eva (Author) , Schneeweiss, Andreas (Author) , Loi, Sherene (Author) , Monturus, Estefanía (Author) , Clark, Emma (Author) , Knott, Adam (Author) , Restuccia, Eleonora (Author) , Benyunes, Mark C (Author) , Cortés, Javier (Author) ,


    Get full text
    Article (Journal) Online Resource
  3. 3

    Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, p... by Swain, Sandra M. (Author) , Kim, Sung-Bae (Author) , Cortés, Javier (Author) , Ro, Jungsil (Author) , Semiglazov, Vladimir (Author) , Campone, Mario (Author) , Ciruelos, Eva (Author) , Ferrero, Jean-Marc (Author) , Schneeweiss, Andreas (Author) , Knott, Adam (Author) , Clark, Emma (Author) , Ross, Graham (Author) , Benyunes, Mark C (Author) , Baselga, José (Author) ,


    Get full text
    Article (Journal) Online Resource